Giving healthcare companies and their stories the exposure they deserve.

THIS WEEK'S FEATURE

Features

Oct 23, 2018

MagnetTx developing combined MRI and linac for cancer radiation therapy

Oct 23, 2018

Closely-held MagnetTx Oncology Solutions filed a 510(k) application with the FDA in September for its Aurora RT device, which combines the accuracy of magnetic resonance imaging (MRI) with linear accelerator (linac) technology for radiation therapy required by cancer patients.

Oct 23, 2018

Past Features

Featured

Oct 16, 2018

Rgenix’s discovery platform identifying novel RNA-regulated cancer targets

Oct 16, 2018

Closely-held Rgenix has identified novel cancer targets regulated by microRNA pathways, which are key drivers of cancer progression, and developed first-in-class treatments that have the potential to modulate these targets.

Oct 16, 2018

Oct 9, 2018

Lobo Genetics enabling safe cannabis use with DNA testing

Oct 9, 2018

Closely-held Lobo Genetics is readying the initial launch in the current quarter of 2018 of its Lobo Cube DNA testing device to bring the science of cannabis genetics to doctors and consumers.

Oct 9, 2018

Oct 2, 2018

CHF Solutions expanding commercialization of Aquadex FlexFlow for fluid overload

Oct 2, 2018

CHF Solutions (NASDAQ:CHFS) has expanded its U.S. commercial team to 13 sales territories for its Aquadex FlexFlow system, an ultrafiltration treatment for patients with fluid overload who have failed diuretic therapy, along with expanded distribution in Europe and Asia.

Oct 2, 2018

Sep 25, 2018

electroCore focused on U.S. launch of gammaCore for acute treatment of episodic cluster headaches and migraines

Sep 25, 2018

With FDA approval in hand for its gammaCore Sapphire therapy for the acute treatment of episodic cluster headaches and migraines, electroCore (NASDAQ:ECOR) is now focused on commercialization and reimbursement efforts in the U.S.

Sep 25, 2018